Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Harbin Jinhua Pharmaceutical is a Chinese pharmaceutical company based in Harbin, Heilongjiang Province, specializing in the manufacture of chemical drugs and traditional Chinese medicines. Founded in 1994, the company operates out of the Limin Development Zone and maintains multiple GMP-certified production lines for capsules, tablets, and granules. Its product portfolio is primarily focused on over-the-counter (OTC) treatments for respiratory ailments, including influenza and the common cold. As a key player in the regional pharmaceutical industry, Harbin Jinhua supplies essential medications to hospitals and pharmacies across China. The company is part of the broader Harbin Jinhua Enterprise Group, which oversees various industrial interests in the region.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Harbin Jinhua Enterprise.